Miniaturized Surgical Robotic Instruments Expand the Possibilities of Surgical Interventions

Food and Healthcare Press Releases Wednesday December 6, 2017 09:35
CALCI, Italy--6 Dec--PRNewswire/InfoQuest
  • MMI S.r.l. Unveils World's Smallest Robotic Wrist

Medical Microinstruments S.r.l. (MMI), a developer of novel robotic solutions for unmet medical needs, today reveals its robotic platform specifically designed for open microsurgery. The platform allows the surgeon to control two tiny articulated microinstruments that simplify reconstruction procedures after traumatic injuries as well as after tumor removal in soft tissue and bones, and offers the potential for improved surgical success rates and patient outcomes.

(Logo: http://mma.prnewswire.com/media/614046/MMI_Srl_Logo.jpg )
(Photo: http://mma.prnewswire.com/media/614047/MMI_Srl_Robotic_Wrist.jpg )
Video - https://www.youtube.com/watch?v=CTg262fMap0

MMI's instruments are equipped with the smallest articulated wrist having a 3-millimeter outer diameter and tips just 150 micron in width. The wrist is the key to performing robotic microsurgery in real clinical settings and allows easy manipulation of small sutures, from 9-0 to 12-0 in size.

"Thanks to the use of advanced materials and novel microfabrication processes, we have designed the smallest articulated wrist to provide microsurgeons unique instrument dexterity and robotic precision," said Massimiliano Simi, Co-founder and VP R&D.

The surgeon operates the microinstruments while sitting at the surgical bedside and looking through the operating microscope. MMI's robotic platform captures surgeon's hand movements and a scaled-down motion is imposed on the microinstruments.

"We have developed this groundbreaking technology together with microsurgeons from the product's conception and the positive feedback and response that we've received along the way has really been overwhelming and led us to believe that we are on the right track in developing a robot by and for microsurgeons," said Hannah Teichmann, Co-founder and VP Clinical.

Prof. Marco Innocenti, Chief of Plastic and Reconstructive Microsurgery at Careggi University Hospital in Florence and MMI's Clinical Advisor, who has presented preclinical work with MMI's robot at 9th Congress of World Society for Reconstructive Microsurgery in Seoul, including 0.35mm arterial robotic anastomosis, remarked:

"In my opinion, the MMI robotic platform will push the frontier of microsurgery forward and beyond the capabilities of the human hand, thus allowing more surgeons to perform more complex procedures but also enabling supermicrosurgery, such as lymph reconstruction, for the more expert ones."

MMI's President and Co-founder, Giuseppe Maria Prisco, estimates the potential annual market opportunity to be in the order of $2.5 billion.
Related links:
http://www.mmimicro.com
Watch the company video on http://www.mmimicro.com/mmi-video
About:

Medical Microinstruments S.r.l. (MMI), founded in 2015, is based in Calci (PI), Italy. The company's mission is to help more surgeons around the world to offer more advanced procedures, while reducing costs for patients, hospitals and for society at large.

Contact:
Vanya Petrova
Relationship Manager
vanya.petrova@mmimicro.com
+39-348-5441025
Source: MMI Srl

Latest Press Release

Merck in Agreement With Cyclica for AI-augmented Screening Platform to Expand Research Capabilities

- Agreement to screen discovery and early development compounds using artificial intelligence and computational biophysics - Cloud-based in silico platform that screens small molecules to determine polypharmacological profiles - Evaluation to include...

Vitality-linked Insurers to Get 100 million People 20% More Active by 2025

Building on the results of the largest behaviour change study on physical activity, Vitality and its global network of insurers have collectively committed to improving the health of millions over the next seven years. This is in line with the World...

World Congress of Cardiology Cardiovascular Health 2018 Opens in Dubai

- Professor David Wood, President of the World Heart Federation, welcomes more than 5000 cardiologists, doctors, nurses, and health and policy experts from around the world to Dubai for WCC 2018 at a time when the opportunities for a sustainable impact...

Data Presented at 2nd Healthy Lung Summit 2018 to Demonstrate Impact of AstraZeneca#s Healthy Lung Partnership Programme

Deepening commitment to drive improvements for patients with respiratory disease across Asia, AstraZeneca with Business Sweden, The Swedish Trade & Invest Council in Taiwan, hosts the second Healthy Lung Summit, ahead of the 2018 Asia Pacific Society...

Encore Medical Education Will Publish the Best of SABCS(R) News From 2018 San Antonio Breast Cancer Symposium (SABCS)

Encore Medical Education will publish the Best of SABCS(R) News highlighting the key findings presented at the 41st San Antonio Breast Cancer Symposium (SABCS(R)), to be held on December 4-8, 2018 in San Antonio, Texas, USA. The Best of SABCS(R) News...

Related Topics